QuidelOrtho
QDEL
#4767
Rank
A$2.83 B
Marketcap
A$41.79
Share price
-0.22%
Change (1 day)
-29.43%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Revenue for QuidelOrtho (QDEL)

Revenue in 2025 (TTM): A$4.23 Billion

According to QuidelOrtho's latest financial reports the company's current revenue (TTM ) is A$4.08 Billion. In 2024 the company made a revenue of A$4.47 Billion an increase over the revenue in the year 2023 that were of A$4.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for QuidelOrtho from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$4.23 B-5.24%
2024 A$4.47 B1.68%
2023 A$4.40 B-8.32%
2022 A$4.79 B104.84%
2021 A$2.34 B8.42%
2020 A$2.16 B182.86%
2019 A$0.76 B3.05%
2018 A$0.74 B108.39%
2017 A$0.35 B33.84%
2016 A$0.26 B-1.27%
2015 A$0.26 B20.43%
2014 A$0.22 B13.68%
2013 A$0.19 B31.22%
2012 A$0.14 B-3.11%
2011 A$0.15 B38.63%
2010 A$0.11 B-38.99%
2009 A$0.18 B0.7%
2008 A$0.18 B34.49%
2007 A$0.13 B0.41%
2006 A$0.13 B6.61%
2005 A$0.12 B25.64%
2004 A$0.10 B-21.53%
2003 A$0.12 B-5.49%
2002 A$0.13 B-5.6%
2001 A$0.14 B18.67%
2000 A$0.12 B
1998 A$80.67 M16.03%
1997 A$69.53 M42.36%
1996 A$48.84 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Meridian Bioscience
VIVO
A$0.50 B-87.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$32.19 B 687.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$65.84 B 1,511.22%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
A$0.18 B-95.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$36.53 B 794.05%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$5.05 B 23.69%๐Ÿ‡บ๐Ÿ‡ธ USA